DISSECTION OF IMMUNOSUPPRESSIVE EFFECT OF FC REGION OF TUMOR-ENHANCING IGG2

[1] ANDERSON NF, 1968, ADV TRANSPLANT, P103

[2] CRUSE JM, 1968, Z IMMUNITATSFORSCH, V135, P449

[3] CRUSE JM, 1967, Z IMMUNITATSFORSCH, V132, P240

[4] CRUSE JM, 1969, FED PROC, V28, P293

[5] CRUSE JM, 1969, AM J PATHOL, V55, pA83

[6] CRUSE JM, 1970, Z IMMUNITATSFORSCH, V140, P259

[7] CRUSE JM, 1965, LAB INVEST, V14, P1554

[8] CRUSE JM, 1970, AM J PATHOL, V59, pA114

[9] CRUSE JM, 1970, AM J PATHOL, V59, pA98

[10] CRUSE JM, 1970, FED PROC, V29, pA625

[1] ANDERSON NF, 1968, ADV TRANSPLANT, P103

[2] CRUSE JM, 1968, Z IMMUNITATSFORSCH, V135, P449

[3] CRUSE JM, 1967, Z IMMUNITATSFORSCH, V132, P240

[4] CRUSE JM, 1969, FED PROC, V28, P293

[5] CRUSE JM, 1969, AM J PATHOL, V55, pA83

[6] CRUSE JM, 1970, Z IMMUNITATSFORSCH, V140, P259

[7] CRUSE JM, 1965, LAB INVEST, V14, P1554

[8] CRUSE JM, 1970, AM J PATHOL, V59, pA114

[9] CRUSE JM, 1970, AM J PATHOL, V59, pA98

[10] CRUSE JM, 1970, FED PROC, V29, pA625